Today: 9 June 2026
Oil stocks face Tuesday open as Venezuela sanctions shift meets OPEC+ supply talk
15 February 2026
2 mins read

Oil stocks face Tuesday open as Venezuela sanctions shift meets OPEC+ supply talk

New York, Feb 15, 2026, 12:37 EST — The session wrapped up with the market closed.

  • Energy stocks in the U.S. are closing out the week with a wave of supply news piling in—think Venezuela licenses, plus the latest OPEC+ production plans.
  • Brent closed out Friday at $67.75 a barrel, while U.S. WTI finished at $62.89—both benchmarks logging weekly declines.
  • The release of U.S. weekly petroleum inventory figures has been pushed to Thursday due to the federal holiday.

Oil traders in the U.S. face Tuesday’s open with a pair of new supply angles in play—an expanded round of Venezuela authorizations from Washington, plus hints from OPEC+ about a possible boost to production starting April.

Timing’s at play here. Wall Street won’t be open Monday—Presidents Day—so traders lose a day to adjust positions ahead of a quieter week that nonetheless features U.S. inventory numbers and fresh signals from oil states.

The inventory schedule gets bumped as well. Instead of its regular slot, the U.S. Energy Information Administration’s Weekly Petroleum Status Report is set for Thursday, Feb. 19, with the federal holiday on Monday pushing things back.

U.S. oil majors didn’t move in sync last session. Exxon Mobil slipped roughly 1% to $148.45. Chevron ticked up 0.7% at $183.74. Shares of ConocoPhillips picked up 0.6%, closing at $111.43, while Occidental advanced 1.2% to $46.07. Oilfield services lagged: SLB shed 0.5%, ending at $50.39. The Vanguard Energy ETF booked a 0.9% gain.

Crude barely budged, but the underlying factors shifted. Brent and WTI edged up on Friday—softer U.S. inflation numbers gave some support, though traders were still weighing chatter about a potential OPEC+ output boost. “Looks like inflation is stabilizing,” said Dennis Kissler, senior VP of trading at BOK Financial, but he flagged the OPEC+ supply angle as the “negative.” U.S. oil rigs dropped by three to 409, Baker Hughes said. Reuters

The U.S. Treasury’s sanctions office handed out two general licenses for Venezuela, clearing Chevron, BP, Shell, Eni, and Repsol to keep up oil and gas operations in the country. Another license greenlights negotiations for fresh investment deals with PDVSA, though companies still need separate permits for that. Chevron called these moves “important steps” for both development and “advancing regional energy security.” Reuters

Refiners are eyeing Venezuela, too. Valero plans to take delivery of as much as 6.5 million barrels of Venezuelan crude in March for its Gulf Coast network, according to Reuters. Executive Randy Hawkins told the outlet that Venezuelan supply could represent a “pretty large part” of Valero’s heavy crude slate in February and March. Shares of Valero last changed hands at $200.17, up about 1.6%. Marathon Petroleum climbed roughly 2.6%, with Phillips 66 not far behind, up about 2.3%. Reuters

OPEC+ remains the main question mark. According to sources speaking to Reuters, the group is considering bringing back production quota hikes starting in April, with eight member producers scheduled to discuss the plan on March 1. Russia’s Deputy Prime Minister Alexander Novak pointed out that demand usually picks up in March and April, which would help “ensure the balance.” Reuters

Oil stocks face a clear headwind here—extra supply tends to pull prices down. Should Venezuelan shipments increase quickly and OPEC+ sticks to its plan for greater output, crude may shed the geopolitical premium that’s been keeping prices buoyant lately.

Once markets are back on Tuesday, the focus turns fast to Thursday’s postponed U.S. inventory data and any headlines ahead of the March 1 OPEC+ gathering. How crude reacts could steer the direction for energy stocks.

Stock Market Today

  • Trump Bull Market May End Soon, But Eli Lilly and Johnson & Johnson Set to Thrive
    June 8, 2026, 7:26 PM EDT. The S&P 500 surged over 23% since Trump's inauguration, fueled by sectors like AI and tech. However, high valuation metrics and inflation pose risks, suggesting the Trump bull market could end soon. Despite this, pharmaceutical giants Eli Lilly and Johnson & Johnson are positioned to continue growth. Eli Lilly leads the obesity drug market with products like Mounjaro and Zepbound, showing strong revenue gains and advancing new treatments. Johnson & Johnson benefits from its diversified healthcare portfolio, providing stability amid economic uncertainties. Investors may find these stocks resilient as broader market gains face headwinds.

Latest articles

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Peso Rebounds, But Mexico’s Next Inflation Print Looms

Peso Rebounds, But Mexico’s Next Inflation Print Looms

9 June 2026
Mexico’s peso edged up 0.09% to 17.4644 per dollar after Iran and Israel paused attacks, but traders turned cautious ahead of Tuesday’s Mexico inflation data, which could shape Banxico rate expectations and impact the peso’s yield advantage that has supported the currency.
T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes
Previous Story

Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop